GEORGE RUSSELL: Open Payments
NPI 1508307448 · SULPHUR, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$228 in 13 payments from 7 companies in 2025. Trend: 2023 $222 · 2024 $176 · 2025 $228
Food & beverage: $228
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $63 |
| Novo Nordisk Inc | 3 | $50 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Dexcom, Inc. | 1 | $24 |
| Antares Pharma, Inc. | 1 | $17 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: MOUNJARO, GEMTESA, Ozempic, Dexcom G6 Transmitter, XYOSTED, JOURNAVX, Rybelsus, FARXIGA.
Industry payments across OK — which companies pay providers there.
